Open Lab
,----[ Quote ]
| The open source wave could soon power drug discovery initiatives in the
| country. A decentralised, web-based initiative is emerging that would enable
| scientists from laboratories, universities, institutes, and drug Companies to
| work together in discovering new drugs for diseases like tuberculosis (TB),
| malaria, various types of cancer, AIDS, Chikungunya, Kala-azar, dengue fever,
| etc.
`----
http://www.financialexpress.com/news/Open-Lab/279490/
So much for intellectual monopolies. Here is how it can be done better:
Fear and Loathing in Open Source Marketing
,----[ Quote ]
| So far Drupal has benefited from the most powerful software development,
| distribution, and marketing mechanisms today. That looks something like this:
|
| 1. Develop a good free product
| 2. Grow a community around that product
| 3. Achieve wide spread adoption and brand recognition
| 4. Find complimentary, not antagonistic, ways to monetize this success
| which is their next step
|
| This formula is what has worked for Red Hat, MySQL, and all indications show
| that it’s working for companies like SugarCRM and Alfresco.
`----
http://socializedsoftware.com/2008/03/01/fear-and-loathing-in-open-source-marketing/
Related:
Open-source model for drug discovery?
,----[ Quote ]
| Significant public funding along with the ability for private enterprise to
| benefit from the open source approach will result in a strong public-private
| partnership and ensure success of the open source approach.
`----
http://economictimes.indiatimes.com/ET_Debates/Open-source_model_for_drug_discovery/articleshow/2651121.cms
Open source drug discovery
,----[ Quote ]
| The idea, taking off from successful open source models such as the human
| genome sequencing initiative, is very simple. All the relevant data and
| accumulated intelligence on a particular disease, tuberculosis to begin with,
| would be hosted online.
`----
http://economictimes.indiatimes.com/Editorials/Open_source_drug_discovery/articleshow/2639296.cms
'Open source' urged for TB drug design effort
,----[ Quote ]
| One of India's top genetics researchers has called for a global,
| collaborative effort to design a new tuberculosis (TB) drug using an 'open
| source' approach.
`----
http://www.scidev.net/news/index.cfm?fuseaction=readnews&itemid=4082&language=1
Open Source Pharmaceuticals - New Business Model
,----[ Quote ]
| Software is not the only field affected by open source; many fields of study
| and social and political views have been affected by the growth of the
| concept of open source. Advocates in one field will often support the
| expansion of open source in other fields, including Linus Torvalds who is
| quoted as saying, "the future is open source everything."
`----
http://www.farmavita.net/content/view/336/
Open source synthetic biology
,----[ Quote ]
| Not everyone within synthetic biology takes the open-source approach, Andrew
| Hessel, an iGEM consultant who recruits teams from Canadian universities,
| told me, but the driving force behind it is iGEM and MIT (Rettberg works with
| renowned hacker-turned-synthetic biologist Tom Knight). Hessel likened the
| atmosphere to the time when computers were first becoming cheap enough to be
| affordable by anyone who wanted one, and young, bright kids began to play
| around with code.
`----
http://www.the-scientist.com/blog/display/53822/
Biology Goes Open Source
,----[ Quote ]
| Some of the world's biggest drug companies are finding that
| their genetic research is worth more to them if they give it away.
`----
http://www.forbes.com/business/2007/02/12/novartis-genes-diabetes-research-biz-cz_mh_0212novartis.html?partner=rss
http://tinyurl.com/2vqssl
Pharmac publishes directly with open source
,----[ Quote ]
| The team used Python, libxml/libxslt and TeX, running on Debian GNU/Linux,
| and the open document standards TeX, XML, MathML, XHTML, and Xlink, says
| Geering.
`----
http://computerworld.co.nz/news.nsf/news/25F72F231ABF8F5ACC2573630083A579
Red Hat scores Swedish pharmacy contract
,----[ Quote
| Apoteket, the pharmacy network, will convert to Red Hat Enterprise Linux
| running on Intel hardware, Red Hat said. Financial terms of the deal were not
| disclosed.
`----
http://biz.yahoo.com/bizj/070918/1522057.html?.v=1
Open Source Research -- the Power of Us
,----[ Quote ]
| Open source methods have delivered tangible benefits in the computer
| science community. We describe here efforts to extend these principles
| to science generally, and in particular biomedical research. Open
| source research holds great promise for solving complex problems in
| areas where profit-driven research is seen to have failed. We
| illustrate this with a specific problem in organic chemistry that
| we think will be solved substantially faster with an open
| source approach.
`----
http://www.publish.csiro.au/view/journals/dsp_journal_fulltext.cfm?nid=51&f=CH06095
Our Biotech Future [is Open Source]
,----[ Quote ]
| Open Source biology could be a powerful tool, giving us access to
| cheap and abundant solar energy.
`----
http://www.nybooks.com/articles/20370
Open-Source Drug Safety?
,----[ Quote ]
| More than a million Americans take Avandia every year; the risk
| Glaxo had found would mean thousands of extra heart attacks. But
| the company argued that the risk only occurred in patients who
| already had serious heart problems, and that it didn't show up
| in long-term clinical trials. The FDA made no decision, and no
| public statement.
|
| [...]
|
| It's an open source approach to drug safety.
`----
http://www.forbes.com/home/sciencesandmedicine/2007/05/21/fda-glaxo-avandia-biz-sci_cx_mh_0522fda.html
Open Source Pharmaceuticals - New Business Model
,----[ Quote ]
| "Open source" as applied to culture defines a culture in which
| intellectual property is made generally available. Participants
| in such a culture are able to improve and modify those products
| and redistribute them back into the community.
`----
http://www.farmavita.net/content/view/336/51/
Thailand fed up with high drug prices - minister
,----[ Quote ]
| "We have thought about this for more than five years. It's long enough,"
| said Mongkol na Songkhla, who is leading one of the biggest challenges to
| Big Pharma's patent rights in years.
`----
http://thestar.com.my/news/story.asp?file=/2007/2/19/worldupdates/2007-02-19T014311Z_01_NOOTR_RTRJONC_0_-288239-1&sec=worldupdates
|
|
